| Next 10 |
Ad
ALX News and Press Alexander's Inc.
News | Alexander's Inc. (NYSE:ALX)
-
2025-02-16 09:00:00 ET Summary US equity markets flirted with fresh record-highs this week while benchmark interest rates hovered around two-month lows as investors weighed positive earnings news against uncomfortable hot inflation data. Complicating the policy outlook for the Fed...
-
2025-02-10 09:41:28 ET More on Alexander's Alexander's: Bloomberg Lease Secured, Is The Dividend Safe Seeking Alpha’s Quant Rating on Alexander's Historical earnings data for Alexander's Dividend scorecard for Alexander's Financial information ...
-
Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares) (AVAL) is expected to report $0.06 for Q4 2024 Boundary Gold & Copper Mng Ltd. (PRZFF) is expected to report for quarter end 2024-11-30 Astera Labs Inc. (ALAB) is expected to report $0.03 for Q4 2024 Sa...
-
2025-02-08 12:00:04 ET More on Real Estate XLRE: Yields Have Eased, It's Time To Consider Real Estate Stocks Mortgage rates drop leading to increased purchase applications Seeking Alpha’s Quant Rating on The Real Estate Select Sector SPDR Fund ETF Re...
-
2025-01-25 22:09:16 ET Summary Alexander's has dipped materially from its 52-week high following a spike in the US 10-year Treasury yield. The REIT generated fiscal 2024 third-quarter FFO of $2.84 per share, down from its year-ago comp. A $354.8 million cash and cash equivalen...
-
2024-12-19 13:05:54 ET More on ALX Oncology Seeking Alpha’s Quant Rating on ALX Oncology Historical earnings data for ALX Oncology Financial information for ALX Oncology Read the full article on Seeking Alpha For further details see: ALX On...
-
2024-12-12 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Alexander's, Inc. (NYSE: ALX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.77% on the day to $227.48. Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metro...
-
2024-11-18 12:09:16 ET More on Aldeyra Therapeutics Aldeyra's FDA Resubmission And AbbVie Option Revitalize Reproxalap's Prospects Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership Seeking Alpha’s Quant Rating on Aldeyra Therapeutics Historic...
-
2024-11-12 06:00:24 ET Summary Alexander's, Inc. has underperformed since 2019, with a -1.7% TSR compared to SPY's 113%, due to declining profitability and rich valuations. Despite increasing NOPAT since 2020, the Company's GAAP net income and NOPAT margins have declined from 2019...
Stock Information
Get ALX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares) (AVAL) is expected to report $0.06 for Q4 2024 Boundary Gold & Copper Mng Ltd. (PRZFF) is expected to report for quarter end 2024-11-30 Astera Labs Inc. (ALAB) is expected to report $0.03 for Q4 2024 Sa...
-
2024-12-12 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Alexander's, Inc. (NYSE: ALX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.77% on the day to $227.48. Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metro...